These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31119166)

  • 1. Clinicopathologic and Prognostic Significance of Body Mass Index (BMI) among Breast Cancer Patients in Western China: A Retrospective Multicenter Cohort Based on Western China Clinical Cooperation Group (WCCCG).
    Wang K; Wu YT; Zhang X; Chen L; Zhu WM; Zhang AJ; Zheng K; Yin XD; Li F; Kong LQ; Ma BL; Li H; Liu JP; Jiang J; Li ZY; Shi Y; Ren GS; Li HY
    Biomed Res Int; 2019; 2019():3692093. PubMed ID: 31119166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between body mass index and immunohistochemical subtypes in breast cancer.
    Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Obesity on Clinicopathologic Characteristics and Disease Prognosis in Pre- and Postmenopausal Breast Cancer Patients: A Retrospective Institutional Study.
    Ayoub NM; Yaghan RJ; Abdo NM; Matalka II; Akhu-Zaheya LM; Al-Mohtaseb AH
    J Obes; 2019; 2019():3820759. PubMed ID: 31019808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of body mass index on pathological complete response and survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Aguiar D; Ros L; Pérez D; Croissier L; Mori M; Hernández M; Vargas AM; Galván S; Antonilli C; Saura S
    Breast Dis; 2022; 41(1):351-361. PubMed ID: 36031886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-institute retrospective study.
    Ozaki Y; Masuda J; Kataoka A; Kogawa T; Abe T; Morizono H; Inagaki L; Hara F; Takano T; Ueno T; Ohno S
    Cancer Rep (Hoboken); 2023 Feb; 6(2):e1695. PubMed ID: 36806718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer.
    Van Baelen K; Nguyen HL; Hamy-Petit AS; Richard F; Karsten MM; Nader Marta G; Vermeulen P; Toussaint A; Reyal F; Vincent-Salomon A; Dirix L; Dordevic AD; de Azambuja E; Larsimont D; Amato O; Maetens M; De Schepper M; Geukens T; Han SN; Baert T; Punie K; Wildiers H; Smeets A; Nevelsteen I; Floris G; Biganzoli E; Neven P; Desmedt C
    Eur J Cancer; 2023 Sep; 191():112988. PubMed ID: 37573673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measured adolescent body mass index and adult breast cancer in a cohort of 951,480 women.
    Keinan-Boker L; Levine H; Derazne E; Molina-Hazan V; Kark JD
    Breast Cancer Res Treat; 2016 Jul; 158(1):157-167. PubMed ID: 27306419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of internal mammary lymph nodes (IMLN) metastasis and disease-free survival comparison between IMLN-positive and IMLN-negative breast cancer patients: Results from Western China Clinical Cooperation Group (WCCCG) database (CONSORT).
    Wang K; Zhang X; Zheng K; Yin XD; Xing L; Zhang AJ; Shi Y; Kong LQ; Li F; Ma BL; Li H; Liu JP; Jiang J; Ren GS; Li HY
    Medicine (Baltimore); 2018 Jul; 97(28):e11296. PubMed ID: 29995764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of overweight and obesity on the pulmonary volumes of patients with breast cancer].
    Muñoz Cofré R; Del Sol Calderon M; Palma Rozas G; Valverde Ampai W; Marzuca Nassr G; Marzuca-Naser GN; Escobar Cabello M; Escobar Cabello M
    Nutr Hosp; 2019 Apr; 36(2):428-433. PubMed ID: 30866637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High body-mass index is not associated with worse clinicopathological characteristics in predominantly obese breast cancer patients.
    Kemal Y; Demirag G; Teker F; Kut E; Kefeli M; Ekiz K; Yucel I
    Exp Oncol; 2015 Dec; 37(4):281-4. PubMed ID: 26710841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients.
    Kim JY; Lee DW; Lee KH; Min A; Ryu HS; Lee HB; Moon HG; Kim TY; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA; Kim S
    Breast Cancer Res Treat; 2019 Jul; 176(2):453-460. PubMed ID: 31028608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
    Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
    Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
    Widschwendter P; Friedl TW; Schwentner L; DeGregorio N; Jaeger B; Schramm A; Bekes I; Deniz M; Lato K; Weissenbacher T; Kost B; Andergassen U; Jueckstock J; Neugebauer J; Trapp E; Fasching PA; Beckmann MW; Schneeweiss A; Schrader I; Rack B; Janni W; Scholz C
    Breast Cancer Res; 2015 Sep; 17(1):129. PubMed ID: 26385214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial.
    Di Cosimo S; Porcu L; Agbor-Tarh D; Cinieri S; Franzoi MA; De Santis MC; Saura C; Huober J; Fumagalli D; Izquierdo M; Piccart M; Daidone MG; de Azambuja E
    Breast Cancer Res; 2020 Oct; 22(1):115. PubMed ID: 33109233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
    Lammers SWM; Thurisch H; Vriens IJH; Meegdes M; Engelen SME; Erdkamp FLG; Dercksen MW; Vriens BEPJ; Aaldering KNA; Pepels MJAE; van de Winkel LMH; Peters NAJB; Tol J; Heijns JB; van de Wouw AJ; Teeuwen NJA; Geurts SME; Tjan-Heijnen VCG
    Breast Cancer Res Treat; 2024 Jan; 203(2):339-349. PubMed ID: 37878148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.
    Sun L; Zhu Y; Qian Q; Tang L
    Medicine (Baltimore); 2018 Jun; 97(26):e11220. PubMed ID: 29952978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Mass Index as a Prognostic Factor in Resected Lung Cancer: Obesity or Underweight, Which Is the Risk Factor?
    Matsunaga T; Suzuki K; Imashimizu K; Banno T; Takamochi K; Oh S
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):551-7. PubMed ID: 26277079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy.
    Takada K; Kashiwagi S; Asano Y; Goto W; Ishihara S; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2021 Oct; 21(1):1129. PubMed ID: 34670511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.